Cancer Focus Fund II, LP

CIK 2069938 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cancer Focus Fund II, LP.

Recent SEC filings

FiledFormAccession number
May 22, 2026D/A0001123292-26-000706
May 23, 2025D0001123292-25-000250